title: Reply to 'Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?'
authors.affiliation: a Klinik für Kinder- und Jugendmedizin, Kinderzentrum Bethel, Evangelisches Klinikum Bethel gGmbH , Akademisches Lehrkrankenhaus der Universität Münster , Bielefeld , Germany.
authors.forename: Eckard
authors.initials: E
authors.lastname: Hamelmann
authors.affiliation: b Department of Pulmonology and Allergy , University Children Hospital Carl Gustav Carus, Technical University of Dresden , Dresden , Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Vogelberg
authors.affiliation: c Department of Pediatrics, Section of Pulmonary Medicine , Pediatric Asthma Research Program, Children's Hospital Colorado (Breathing Institute) , Aurora , CO , USA.|d University of Colorado School of Medicine , Aurora , CO , USA.
authors.forename: Stanley J
authors.initials: SJ
authors.lastname: Szefler
mesh_terms: D000293:Adolescent; D018927:Anti-Asthmatic Agents; D001249:Asthma; D001993:Bronchodilator Agents; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide
chemical_list: D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide